tirzepatide weight loss surmount-1 results percent weight loss 72 weeks Trial SURMOUNT-1: Tirzepatide Drastically Reduces Weight

Zhou, L., Qu, H., Yang, L., & Shou, L

These advantages translate into longer shelf life and more predictable degradation profiles

For the glucose-lowering indication, these are categorised as: Very common (affecting one in every 10 people): Nausea, diarrhoea, hypoglycaemia when used with a sulfonylurea or insulin

Avoid greasy, fried, or very spicy foods

Mounjaro and Wegovy are two of the most well-known weight loss medications, so we've created this guide to help you understand the difference between them, and whether there are any alternative treatments that may help you reach your weight loss goals

At 17mg/mL, 2.5mg equals approximately 14.7 units